Dare Bioscience, Inc. Quarterly Other Assets, Noncurrent in USD from Q4 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Dare Bioscience, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2013 to Q2 2024.
  • Dare Bioscience, Inc. Other Assets, Noncurrent for the quarter ending June 30, 2024 was $529K, a 42.6% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $529K -$392K -42.6% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $655K -$145K -18.1% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $600K +$345K +136% Dec 31, 2023 10-Q 2024-08-12
Q3 2023 $796K +$59.9K +8.14% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $921K -$340K -27% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $799K -$545K -40.5% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $254K -$231K -47.6% Dec 31, 2022 10-K 2024-03-28
Q3 2022 $737K +$201K +37.6% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $1.26M +$523K +70.8% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $1.34M +$456K +51.4% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $485K -$43.8K -8.27% Dec 31, 2021 10-K 2023-03-30
Q3 2021 $535K -$99.7K -15.7% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $738K -$373 -0.05% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $888K +$47.3K +5.63% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $529K -$406K -43.5% Dec 31, 2020 10-K 2022-03-31
Q3 2020 $635K +$2.31K +0.37% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $739K +$46.4K +6.7% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 $841K +$89.2K +11.9% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 $935K +$357K +61.8% Dec 31, 2019 10-K 2021-03-30
Q3 2019 $633K +$15.1K +2.45% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $692K +$35.3K +5.37% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $751K +$65.3K +9.52% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 $578K -$145K -20.1% Dec 31, 2018 10-K 2020-03-27
Q3 2018 $617K +$615K +21954% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 $657K +$654K +23365% Jun 30, 2018 10-Q 2018-08-13
Q1 2018 $686K +$456K +198% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 $723K +$711K +5604% Dec 31, 2017 10-K 2019-04-01
Q3 2017 $2.8K -$227K -98.8% Sep 30, 2017 10-Q 2017-11-13
Q2 2017 $2.8K -$227K -98.8% Jun 30, 2017 8-K/A 2017-10-02
Q1 2017 $230K $0 0% Mar 31, 2017 10-Q 2017-05-12
Q4 2016 $12.7K -$334K -96.3% Dec 31, 2016 10-K 2018-03-28
Q3 2016 $230K -$380K -62.3% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 $230K -$423K -64.8% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 $230K -$239K -51% Mar 31, 2016 10-Q 2016-05-02
Q4 2015 $347K +$132K +61.4% Dec 31, 2015 10-K/A 2017-06-13
Q3 2015 $610K +$490K +408% Sep 30, 2015 10-Q 2015-11-16
Q2 2015 $653K +$529K +427% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 $469K +$339K +261% Mar 31, 2015 10-Q 2015-05-06
Q4 2014 $215K +$80K +59.3% Dec 31, 2014 10-K 2016-03-10
Q3 2014 $120K Sep 30, 2014 10-Q 2014-11-13
Q2 2014 $124K Jun 30, 2014 10-Q 2014-08-12
Q1 2014 $130K Mar 31, 2014 10-Q 2014-05-27
Q4 2013 $135K Dec 31, 2013 10-K 2015-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.